438 related articles for article (PubMed ID: 20732355)
1. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
Monti JM; Jantos H
Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
[TBL] [Abstract][Full Text] [Related]
2. Serotonin control of sleep-wake behavior.
Monti JM
Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
[TBL] [Abstract][Full Text] [Related]
3. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
[TBL] [Abstract][Full Text] [Related]
4. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.
Kantor S; Jakus R; Balogh B; Benko A; Bagdy G
Br J Pharmacol; 2004 Aug; 142(8):1332-42. PubMed ID: 15265808
[TBL] [Abstract][Full Text] [Related]
5. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
6. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.
Monti JM; Jantos H; Schechter LE
Behav Brain Res; 2013 Jul; 249():65-74. PubMed ID: 23624323
[TBL] [Abstract][Full Text] [Related]
7. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
Monti JM; Jantos H; Lagos P
Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat.
Monti JM; Leopoldo M; Jantos H
Behav Brain Res; 2014 Feb; 259():321-9. PubMed ID: 24286819
[TBL] [Abstract][Full Text] [Related]
9. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
Monti JM; Jantos H
Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
[TBL] [Abstract][Full Text] [Related]
10. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
Monti JM; Leopoldo M; Jantos H
Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
Monti JM; Jantos H; Catenaccio V; Xavier S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
[TBL] [Abstract][Full Text] [Related]
12. Microinjection of the melanin-concentrating hormone into the lateral basal forebrain increases REM sleep and reduces wakefulness in the rat.
Lagos P; Monti JM; Jantos H; Torterolo P
Life Sci; 2012 Jun; 90(23-24):895-9. PubMed ID: 22579511
[TBL] [Abstract][Full Text] [Related]
13. Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat.
Monti JM; Jantos H
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1189-95. PubMed ID: 16713054
[TBL] [Abstract][Full Text] [Related]
14. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
Fornal C; Radulovacki M
J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
[TBL] [Abstract][Full Text] [Related]
15. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.
Monti JM
Sleep Med Rev; 2010 Oct; 14(5):319-27. PubMed ID: 20153670
[TBL] [Abstract][Full Text] [Related]
16. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
Monti JM; Jantos H
Behav Brain Res; 2006 Feb; 167(2):245-50. PubMed ID: 16290281
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.
Cavas M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats.
Adamec R; Creamer K; Bartoszyk GD; Burton P
Eur J Pharmacol; 2004 Nov; 504(1-2):79-96. PubMed ID: 15507224
[TBL] [Abstract][Full Text] [Related]
20. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
Monti JM; Leopoldo M; Jantos H; Lagos P
Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
